900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Alpha blocking vasodilator adverse reaction	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha blocking vasodilator allergy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
forgiftning med alpha-chloralose	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha heavy chain disease	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha heavy chain disease	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha thalassaemia (& homozygous)	Ambiguous
Alpha thalassaemia trait	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha thalassemia trait	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
syndrom med alfa-talassami og mental retardering	Ambiguous
Alpha tocopheryl acetate 500mg/5mL suspension	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
alphatocopherylacetat 50 IE/g creme	A component that fails to comply with the current editorial guidance.
Alpha tocopheryl product	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
alphatocopherylsuccinat	A component that fails to comply with the current editorial guidance.
måling af alfa-1-føtoprotein i spinalvæske	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-1-antitrypsin deficiency	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-1-antitrypsin phenotype	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-1-antitrypsin phenotype	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-1-antitrypsin phenotype	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-1-antitrypsin phenotype	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-2-antiplasmin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-2-antiplasmin level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-2-antitrypsin deficiency	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-L-iduronidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
alpha-amylasespecifikt ekstrakt	Erroneous component (foundation metadata concept)
Alpha-feto protein blood test (& [antenatal])	Ambiguous
Alpha-feto protein blood test (& [antenatal])	Ambiguous
Alpha-fetoprotein (AFP) blood test NOS	Classification derived component
Alpha-fetoprotein NOS	Classification derived component
Alpha-fetoprotein NOS	Classification derived component
blodprøve for AFP ikke tilbudt	A component that fails to comply with the current editorial guidance.
Alpha-fetoprotein blood test not offered	A component that fails to comply with the current editorial guidance.
blodprøve for AFP tilbudt	A component that fails to comply with the current editorial guidance.
Alpha-fetoprotein equivocal	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-fetoprotein low	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-fetoprotein normal	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-fetoprotein radioimmunoassay	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-fetoprotein raised	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-fucosidase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-galactosidase A	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-galactosidase A deficiency	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpha-galactosidase A deficiency	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alfa-glucosid-hæmmer	Ambiguous
tilskud bestående af alfa-linolensyre	A component that fails to comply with the current editorial guidance.
alfa/beta-lipoproteinæmi	Ambiguous
Alpha/beta-adrenergic blocking agent	Ambiguous
alpha1-proteinasehæmmer	A component that is no longer current, useful, appropriate or acceptable.
Alpha1-proteinase inhibitor	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alphaherpesvirus group	A component that is no longer current, useful, appropriate or acceptable.
Alphavirus	Ambiguous
Alphavirus antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alphavirus antibody level	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alpine Chamoisee goat breed	Moved elsewhere
Alpine dachsbracke dog breed	Moved elsewhere
Alpine goat	Moved elsewhere
Alports syndrom-lignende hereditær nefrit	Ambiguous
Alport's syndrome	Ambiguous
Alport's syndrome	Ambiguous
Alport's syndrome	Ambiguous
Alprazolam - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alprazolam 0.25mg tablet	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alprazolam 0.5mg tablet	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
alprazolam 1 mg/ml koncentrat	Ambiguous
overdosis af alprazolam, uvist med hvilken hensigt	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
forgiftning med alprazolam, uvist med hvilken hensigt	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alprostadil	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder	A component that fails to comply with the current editorial guidance.
Alprostadil - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
alprostadil 10,16 µg/ml opløsning	A component that is no longer current, useful, appropriate or acceptable.
alprostadil suppositorium a 1000 µg	Ambiguous
alprostadil 1000 µg pellet	Ambiguous
alprostadil 10 µg cylinderampul med injektionsvæske i sprøjte	A component that fails to comply with the current editorial guidance.
Alprostadil 10micrograms injection (pdr for recon)	Ambiguous
Alprostadil 10micrograms injection (pdr for recon)	Ambiguous
alprostadil 10 µg cylinderampul med injektionsvæske, startpakning	Ambiguous
alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul	Ambiguous
alprostadil 10 µg pulver og solvens til injektionsvæske, opløsning, hætteglas	Ambiguous
alprostadil suppositorium a 125 µg	Ambiguous
alprostadil 125 µg pellet	Ambiguous
alprostadil 20,2 µg/ml opløsning	A component that is no longer current, useful, appropriate or acceptable.
alprostadil 20 µg cylinderampul med injektionsvæske i sprøjte	A component that fails to comply with the current editorial guidance.
Alprostadil 20micrograms injection (pdr for recon)	Ambiguous
Alprostadil 20micrograms injection (pdr for recon)	Ambiguous
alprostadil 20 µg cylinderampul med injektionsvæske, startpakning	Ambiguous
alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul	Ambiguous
alprostadil 20 µg pulver og solvens til injektionsvæske, opløsning, hætteglas	Ambiguous
alprostadil suppositorium a 250 µg	Ambiguous
alprostadil 250 µg pellet	Ambiguous
alprostadil 40,0 µg pulver	A component that fails to comply with the current editorial guidance.
alprostadil 40 µg cylinderampul med injektionsvæske, startpakning	A component that is no longer current, useful, appropriate or acceptable.
alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, cylinderampul	A component that is no longer current, useful, appropriate or acceptable.
alprostadil 40 µg pulver og solvens til injektionsvæske, opløsning, hætteglas	Ambiguous
Alprostadil 40micrograms powder for conventional release solution for injection cartridge	A component that is no longer current, useful, appropriate or acceptable.
alprostadil 500 µg injektionsvæske, opløsning, hætteglas	A component that fails to comply with the current editorial guidance.
alprostadil suppositorium a 500 µg	Ambiguous
Alprostadil 500mcg/mL injection	A component that fails to comply with the current editorial guidance.
alprostadil 500 µg pellet	Ambiguous
alprostadil 500 µg/ml koncentrat til infusionsvæske, ampul a 1 ml	A component that is no longer current, useful, appropriate or acceptable.
Alprostadil 5mcg/mL powder	Ambiguous
alprostadil 5 µg pulver og solvens til injektionsvæske, opløsning, hætteglas	Ambiguous
Alprostadil [erectile dysfunction]	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Alseroxylon - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 94 of 1405 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)